Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

During the Trading Day
6.38 -0.16 / -2.45%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.35 -0.03 / -0.47%
 
Volume: 2.5K

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Oramed Pharmaceuticals Inc have a median target of 27.00, with a high estimate of 27.00 and a low estimate of 27.00. The median estimate represents a +323.20% increase from the last price of 6.38.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Oramed Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.21
Sales
$0.00
Reporting Date
Jan 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -44.83%
 
 
 
 
 
 
Growthannually -46.03%
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account